Evidence map›Paper›PMID 31451651›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Encounter complexes and hidden poses of kinase-inhibitor binding on the free-energy landscape.

Suyong Re, Hiraku Oshima, Kento Kasahara, Motoshi Kamiya, Yuji Sugita

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structural basis for TNIP1 binding to FIP200 during mitophagy.The Journal of biological chemistry · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Molecular dynamics in multidimensional space explains how mutations affect the association path of neomycin to a riboswitch.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suyong ReLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, 650-0047 Kobe, Japan.ORCID 0000-0002-3752-6554
Hiraku OshimaLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, 650-0047 Kobe, Japan.
Kento KasaharaLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, 650-0047 Kobe, Japan.
Motoshi KamiyaComputational Biophysics Research Team, RIKEN Center for Computational Science, 650-0047 Kobe, Japan.
Yuji SugitaLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, 650-0047 Kobe, Japan; sugita@riken.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modern drug discovery increasingly focuses on the drug-target binding kinetics which depend on drug (un)binding pathways. The conventional molecular dynamics simulation can observe only a few binding events even using the fastest supercomputer. Here, we develop 2D gREST/REUS simulation with enhanced flexibility of the ligand and the protein binding site. Simulation (43 μs in total) applied to an inhibitor binding to c-Src kinase covers 100 binding and unbinding events. On the statistically converged free-energy landscapes, we succeed in predicting the X-ray binding structure, including water positions. Furthermore, we characterize hidden semibound poses and transient encounter complexes on the free-energy landscapes. Regulatory residues distant from the catalytic core are responsible for the initial inhibitor uptake and regulation of subsequent bindings, which was unresolved by experiments. Stabilizing/blocking of either the semibound poses or the encounter complexes can be an effective strategy to optimize drug-target residence time.

Indexed as

EntropyProtein BindingBinding SitesBiophysical PhenomenaCatalytic DomainKineticsLigandsMolecular Dynamics SimulationProtein ConformationProtein DomainsProtein Kinase InhibitorsThermodynamicsX-Ray DiffractionLigandsProtein Kinase Inhibitorsfree-energy landscapemolecular dynamics simulationprotein kinaseprotein–ligand interactionreplica-exchange molecular dynamics

Identifiers

PMID31451651
PMCPMC6744929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.